Sarepta Therapeutics

NASDAQ: SRPT
$107.67
-$5.96 (-5.2%)
Closing price February 27, 2020

Top Analyst Upgrades and Downgrades: Carnival, Caterpillar, Darden Restaurants, Fiserv, KeyCorp, Micron, Phillips 66 and More

The market opened lower this morning after posting an intraday all-time high for the S&P 500 yesterday. Concerns over Iran after allegedly shooting down a U.S. Air Force drone and ...
Read Full Story »

Which Gene Therapy Companies May Be Most Valuable After Spark Therapeutics Buyout

Spark Therapeutics Inc. (NASDAQ: ONCE) shares more than doubled in Tuesday’s session as the result of its pending acquisition. However, the root of the buyout was its gene therapy, which ...
Read Full Story »

Credit Suisse Issues Top Outperform Stock Picks for 2019

Almost every December it seems that investors stop thinking about the prior 11 months and turn their attention to how they want to position their investments for the new year. With ...
Read Full Story »

8 Large Insider Buying Trades That Are Too Big to Ignore

  After a big stock market sell-off and a subsequent snap-back rally, it's always interesting to see how corporate directors are acting toward their own shares. It's no secret that ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Chevron, First Data, JD.com, MongoDB, PG&E, Rite Aid, Tilray, Vodafone and More

Stocks were indicated marginally higher on Thursday, but not so much that the direction of the trading day looked set in stone. The major market equity indexes recently hit all-time ...
Read Full Story »

7 Biotech Stocks Insiders Are Loading Up On

Biotechnology stocks have a reputation for being some of the most speculative, most volatile stocks out there. Investors and would-be investors have to stay alert to avoid getting burned. One ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Akamai, Apple, AutoZone, Dropbox, EA, Ford, Kinder Morgan, Pandora, P&G, Shopify and More

The major equity indexes were looking for direction on Wednesday morning ahead of the Federal Reserve's decision on interest rates. Earnings season is still going strong, with dozens of household ...
Read Full Story »

Why Sarepta Shares Are Skyrocketing

Sarepta Therapeutics Inc. (NASDAQ: SRPT) shares skyrocketed on Tuesday after the firm presented positive preliminary results from its midstage Duchenne muscular dystrophy (DMD) trial. Specifically, the results came from Sarepta’s ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AMC, Alkermes, Echostar, Kohls, L Brands, US Bancorp, Sarepta Therapeutics and More

The futures traded just a touch higher Friday morning as the market continued to digest some big gains from the past two weeks. Stocks took off once again yesterday when ...
Read Full Story »

4 Red-Hot Biotech Stocks to Buy Before Earnings

If there is any industry that can blow hot and then very cold on Wall Street, it’s biotechnology, and with good reason. Like big pharmaceuticals, politicians love to target biotechs ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AMD, Altice, Century Aluminum, Cerner, Chipotle, Cigna, GE, Micron, Noble Energy and More

Stocks were mixed on Monday, but Tuesday's indexes were indicated higher after core inflation remained under 2%. Now that the bull market is over nine years old, investors have to ...
Read Full Story »

Top Analyst Upgrades and Downgrades: BioMarin, CSX, Kinder Morgan, Microsemi, Splunk, US Steel, Walmart and More

The stock market fell handily on the first day of March after steel and aluminum tariffs sparked fears of a trade war, and the major indexes were indicated lower on ...
Read Full Story »

Top Analyst Upgrades & Downgrades: Callaway, Capital One, Sarepta, Tesla, UnitedHealth, Wayfair and More

Stocks have been challenging their all-time highs heading into year's end. The Dow Jones Industrial Average is up about 25% and the S&P 500 has returned about 20%, if dividends ...
Read Full Story »

RBC Out With Top Pick Biotech Stocks to Buy for 2018

During the election battle, and for a while after, the health care stocks, including biotechnology and big pharmaceutical, were constantly buffeted by threats over drug pricing and other potential changes ...
Read Full Story »

Sarepta Takes Another Big Step Forward With DMD Treatment

Sarepta Therapeutics Inc. (NASDAQ: SRPT) saw its shares hit a new multiyear high on Friday after the firm announced that it received a key approval from the U.S. Food and ...
Read Full Story »